Year: 2017
Type: article
Abstract: Ras is at the hub of signal transduction pathways controlling cell proliferation and survival. Its mutants, present in about 30% of human cancers, are major drivers of oncogenesis and render tumors unresponsive to standard therapies. Here we report the engineering of a protein scaffold for preferential binding to K-Ras G12D. This is the first reported inhibitor to achieve nanomolar affinity while exhibiting specificity for mutant over wild type (WT) K-Ras. Crystal structures of the protein R11.1.6 in complex with K-Ras WT and K-Ras G12D offer insight into the structural basis for specificity, highlighting differences in the switch I conformation as the major defining element in the higher affinity interaction. R11.1.6 directly blocks interaction with Raf and reduces signaling through the Raf/MEK/ERK pathway. Our results support greater consideration of the state of switch I and provide a novel tool to study Ras biology. Most importantly, this work makes an unprecedented contribution to Ras research in inhibitor development strategy by revealing details of a targetable binding surface. Unlike the polar interfaces found for Ras/effector interactions, the K-Ras/R11.1.6 complex reveals an extensive hydrophobic interface that can serve as a template to advance the development of high affinity, non-covalent inhibitors of K-Ras oncogenic mutants.
Source: Scientific Reports
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
Awards: G1787442886, G2360436881, G4951618211, MRI: Acquisition of X-Ray protein crystallography equipment at Northeastern University, Engineered Antibody EGFR Antagonist Cancer Therapeutics, A Hyperstable Minimalist Protein for Molecular Recognition, G5735053113, Localizing Immunotherapy to Improve Therapeutic Index, Acquisition of Octet Biolayer Interferometry system for MIT biophysics facility, Development of Multi-User Facility for the Study of Complex Macromolecular Systems, Allosteric elements in the superfamily of small GTPases, Cancer Center Support (Core) Grant
OpenAlex ID: W2734751189
